FAP and cancer: The cross reactivity of FAP-CAR T cells brings us convenience to somewhat investigate the contributions of CAFs ablation to tumor progression in allografted mice models, and need not to use conventional xenograft mouse models in which human cancer cells with human CAFs are co-injected (5).